2020 Stop-Loss Research Report High-cost claims and injectable drug trends analysis

In this report, the expanded high-cost claim conditions analysis
that was published as an early release in May is combined with
our new top 20 injectable drugs list and the latest data on million-
dollar+ claims. A healthcare update is also included, covering what
we have seen to date on COVID-19 claims, the latest information
on Zolgensma and a new emerging gene therapy, and several
legislative updates.

Fill out the form below to get your free copy of the “High-cost claims and injectable drug trends analysis."

*All fields are required.
First Name*
Last Name*
Email*
Company*
Street Address*
Zip Code*
Phone*
Role*

SLPC 29609 06/19 (exp. 06/21)